Funds Holding Keryx Biopharmaceuticals, Inc.

Also showing items for ETFS Holding Keryx Biopharmaceuticals, Inc.

 
Stock Quotes for Keryx Biopharmaceuticals, Inc. top ^
  • Industry: Biotechnology
  • Sector: Healthcare
  • Stock Style: Small Growth
  • Stock Type: Distressed
Sign-up for kerx investment picks

 
News Articles for Keryx Biopharmaceuticals, Inc. top ^
2015/1/7
NEW YORK, Jan.
Sign-up for Keryx Biopharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference investment picks
2015/1/8
In 2014, Keryx Biopharmaceuticals needed to quickly build a commercial foundation for product sales and marketing to support its first FDA-approved product, Auryxia™ (ferric citrate). Keryx required a best-of-breed solution that would enable business agility and continuous improvement, plus easily accommodate change and rapid growth.
Sign-up for Keryx Biopharmaceuticals Turns to Veeva Commercial Cloud to Support First FDA-Approved Product Launch investment picks
2015/1/11
NEW YORK and BOSTON, Jan.
Sign-up for Keryx Biopharmaceuticals Announces Transition of Leadership investment picks
2015/1/21
NEW YORK, Jan.
Sign-up for Keryx Biopharmaceuticals, Inc. Announces Pricing of $110 Million Public Offering of Common Stock investment picks
2015/1/20
NEW YORK, Jan.
Sign-up for Keryx Biopharmaceuticals, Inc. Announces $100 Million Proposed Public Offering of Common Stock investment picks
2015/2/25
NEW YORK, Feb.
Sign-up for Keryx Biopharmaceuticals Announces Participation at Upcoming Investor Conferences investment picks

Premium Membership: Features and Benefits
Wide-Moat Screener for Stocks

Put a moat around your portfolio. Sniff out the most promising opportunities that can ride through any market.

Gold Medalist Screener for Funds

Narrow the available universe of 5000 funds to the top rated gold and silver. Then, sort for manager tenure, expense ratio, risk and return to create your own index-beating fund watchlist.

Thousands of Premium Analyst Reports

While many of our competitors measure a stock's worth with a computer program, Morningstar's staff of 150+ analyst sift through company fillings, financial data and a wealth of other sources to deliver an unvarnished review of any investment. In fact, twelve Morningstar analysts have been recognized by WSJ as "Best on the Street" in the US.

Premium Portfolio Monitor

Make decisions with confidence. Load your investments into our research center and automatically connect to all our proprietary tools and data points.

Mobile

Never be without critical research. Free with your active membership, take our Premium data and guidance wherever you go with Morningstar for iPad®, iPhone®, and Android apps.

Morningstar's Guarantee

We're looking out for you. If after your 14-day free trial, you find that a Morningstar Premium membership is not for you, cancel any time and we'll be happy to refund the unused portion - no questions asked.

Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Funds Holding Keryx Biopharmaceuticals, Inc.
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Title |  Date |  Author |  Collection |  Interest |  Popularity Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry |  Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry

Previous: Funds Holding Kerry Properties Ltd.  |  Next: Funds Holding Key Energy Services, Inc.